Antipsychotic drugs are the primary treatment for psychosis, yet individual response to their
administration remains variable. At present, no biological predictors of response exist to …

Studies that have used structural magnetic resonance imaging (MRI) suggest that
individuals with psychoses have brain alterations, particularly in frontal and temporal …

Identifying neurobiological predictors of response to antipsychotics in patients with
schizophrenia is a critical goal of translational psychiatry. Few studies, however, have …

We systematically reviewed twentyone functional neuroimaging studies that used
longitudinal designs to investigate the effects of medication treatments on brain functioning …

Context Most of what we know about antipsychotic drug effects is at the receptor level, distal
from the neural system effects that mediate their clinical efficacy. Studying cerebral function …

Despite the availability of several drugs, about 30% of patients with schizophrenia still fail to
respond properly to a course of appropriate antipsychotic treatment. Functional …

The evidence that antipsychotics improve brain function and reduce symptoms in
schizophrenia is unmistakable, but how antipsychotics change brain function is poorly …

Background Cross-sectional neuroanatomical studies have reported abnormalities in
schizophrenia that relate to disease variables. Longitudinal neuroimaging investigations that …

Abstract Magnetic Resonance Imaging (MRI) measures are promising outcome markers for
schizophrenia, since regional frontal and temporal grey matter volumes reductions, and …

Electroconvulsive therapy (ECT) has been shown to be effective in schizophrenia,
particularly when rapid symptom reduction is needed or in cases of resistance to drug …